1. A phase I study of the PD-L1 inhibitor, durvalumab, in combination with a PARP inhibitor, olaparib, and a VEGFR1–3 inhibitor, cediranib, in recurrent women's cancers with biomarker analyses. Issue 1 (25th July 2019) Authors: Zimmer, Alexandra S.; Nichols, Erin; Cimino-Mathews, Ashley; Peer, Cody; Cao, Liang; Lee, Min-Jung; Kohn, Elise C.; Annunziata, Christina M.; Lipkowitz, Stanley; Trepel, Jane B.; Sharma, Rajni; Mikkilineni, Lekha; Gatti-Mays, Margaret; Figg, William D.; Houston, Nicole D.; Lee, Jung-Min Journal: Journal for immunotherapy of cancer Issue: Volume 7:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Assessment of Adult Women With Ovarian Masses and Treatment of Epithelial Ovarian Cancer: ASCO Resource-Stratified Guideline. (2021) Authors: Vanderpuye, Verna D.; Clemenceau, Jean Rene V.; Temin, Sarah; Aziz, Zeba; Burke, William M.; Cevallos, Nixon Leonardo; Chuang, Linus T.; Colgan, Terence J.; del Carmen, Marcela G.; Fujiwara, Keiichi; Kohn, Elise C.; Gonzáles Nogales, Jose Enrique; Konney, Thomas Okpoti; Mukhopadhyay, Asima; Paude... Journal: JCO global oncology Issue: Volume 7(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Assessment of Adult Women With Ovarian Masses and Treatment of Epithelial Ovarian Cancer: ASCO Resource-Stratified Guideline. Issue 2 (February 2022) Authors: Vanderpuye, Verna D.; Clemenceau, Jean Rene V.; Temin, Sarah; Aziz, Zeba; Burke, William M.; Cevallos, Nixon Leonardo; Chuang, Linus T.; Colgan, Terence J.; del Carmen, Marcela G.; Fujiwara, Keiichi; Kohn, Elise C.; Nogales, Jose Enrique Gonzáles; Konney, Thomas Okpoti; Mukhopadhyay, Asima; Paude... Journal: Obstetrical & gynecological survey Issue: Volume 77:Issue 2(2022) Page Start: 96 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Assessment of Adult Women With Ovarian Masses and Treatment of Epithelial Ovarian Cancer: ASCO Resource-Stratified Guideline. Issue 2 (February 2022) Authors: Vanderpuye, Verna D.; Clemenceau, Jean Rene V.; Temin, Sarah; Aziz, Zeba; Burke, William M.; Cevallos, Nixon Leonardo; Chuang, Linus T.; Colgan, Terence J.; del Carmen, Marcela G.; Fujiwara, Keiichi; Kohn, Elise C.; Nogales, Jose Enrique Gonzáles; Konney, Thomas Okpoti; Mukhopadhyay, Asima; Paude... Journal: Obstetrical & gynecological survey Issue: Volume 77:Issue 2(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Cediranib, a pan-VEGFR inhibitor, and olaparib, a PARP inhibitor, in combination therapy for high grade serous ovarian cancer. (3rd May 2016) Authors: Ivy, S. Percy; Liu, Joyce F.; Lee, Jung-Min; Matulonis, Ursula A.; Kohn, Elise C. Journal: Expert opinion on investigational drugs Issue: Volume 25:Number 5(2016:May) Page Start: 597 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Clinical Trials in Gynecologic Oncology: Past, Present, and Future. Issue 5 (May 2018) Authors: Annunziata, Christina M.; Kohn, Elise C. Journal: Obstetrical & gynecological survey Issue: Volume 73:Issue 5(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Critical questions in ovarian cancer research and treatment: Report of an American Association for Cancer Research Special Conference. Issue 12 (5th March 2019) Authors: Bast, Robert C.; Matulonis, Ursula A.; Sood, Anil K.; Ahmed, Ahmed A.; Amobi, Adaobi E.; Balkwill, Frances R.; Wielgos‐Bonvallet, Monicka; Bowtell, David D. L.; Brenton, James D.; Brugge, Joan S.; Coleman, Robert L.; Draetta, Giulio F.; Doberstein, Kai; Drapkin, Ronny I.; Eckert, Mark A.; Edwards... Journal: Cancer Issue: Volume 125:Issue 12(2019) Page Start: 1963 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Defining and targeting wild-type BRCA high-grade serous ovarian cancer: DNA repair and cell cycle checkpoints. (2nd September 2019) Authors: Ivy, S. Percy; Kunos, Charles A.; Arnaldez, Fernanda I.; Kohn, Elise C. Journal: Expert opinion on investigational drugs Issue: Volume 28:Number 9(2019) Page Start: 771 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Does one size fit all? The updated ovarian cancer staging: Still a work in progress. Issue 19 (25th June 2015) Authors: Duska, Linda R.; Kohn, Elise C. Journal: Cancer Issue: Volume 121:Issue 19(2015) Page Start: 3384 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Drug development and registration: Challenges and opportunities in ovarian cancer. Issue 14 (12th May 2017) Authors: Ivy, S. Percy; Kohn, Elise C. Journal: Cancer Issue: Volume 123:Issue 14(2017) Page Start: 2597 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗